GRI Bio, Inc. (GRI) SEC Filings & Financial Intelligence
GRI Bio, Inc. (GRI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GRI
CIK: 1824293
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerRobert Thomas
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| ARS | 2026-09-28 | 2025-12-31 | ARS | 0001824293-26-000061 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-28 | 2026-11-04 | DEF 14A | 0001824293-26-000060 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001824293-26-000057 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001824293-26-000055 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088829 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | 8-K | 0001824293-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001824293-26-000046 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-055884 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001824293-26-000044 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-016505 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-10 | — | SCHEDULE 13G/A Filing | 0001493152-26-005944 | View SEC Doc Filr Page |
| 8-K | 2026-02-04 | 2026-02-04 | 8-K | 0001824293-26-000040 | View SEC Doc Filr Page |
| EFFECT | 2026-01-30 | — | EFFECT Filing | 9999999995-26-000436 | View SEC Doc Filr Page |
| CORRESP | 2026-01-30 | — | CORRESP Filing | 0001824293-26-000036 | View SEC Doc Filr Page |
| UPLOAD | 2026-01-30 | — | UPLOAD Filing | 0000000000-26-001119 | View SEC Doc Filr Page |
| 10-K | 2026-01-30 | 2025-12-31 | 10-K | 0001824293-26-000033 | View SEC Doc Filr Page |
| 8-K | 2026-01-30 | 2026-01-29 | 8-K | 0001824293-26-000030 | View SEC Doc Filr Page |
| 424B5 | 2026-01-30 | — | 424B5 | 0001824293-26-000029 | View SEC Doc Filr Page |
| S-3 | 2026-01-30 | — | S-3 | 0001824293-26-000028 | View SEC Doc Filr Page |
| S-8 | 2026-01-30 | — | S-8 | 0001824293-26-000027 | View SEC Doc Filr Page |
| 8-K | 2026-01-28 | 2026-01-28 | 8-K | 0001824293-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-01-21 | 2026-01-21 | 8-K | 0001824293-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-01-16 | 2026-01-15 | 8-K | 0001824293-26-000011 | View SEC Doc Filr Page |
| 8-K | 2026-01-15 | 2026-01-15 | 8-K | 0001824293-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-01-09 | 2026-01-09 | 8-K | 0001824293-26-000006 | View SEC Doc Filr Page |